Skip to main content

Non-Small Cell Cancer of the Lung

  • Chapter
  • 261 Accesses

Conclusions

Resection is the accepted treatment for patients with stage I or II lung cancer; unfortunately, only 25% of patients fall into this category. Following resection, adjuvant therapy has no proven benefit for stage I or II patients. If stage IIIA (N2) disease is suspected on clinical grounds (CT scan, PET scan) and is confirmed histologically (needle biopsy or mediastinoscopy), initial surgery is generally contraindicated. Instead, chemotherapy and radiation are administered to downstage the lesion and potentially render it resectable. If unsuspected, pathologic stage IIIA (N2) disease is discovered following thoracotomy and lobectomy, postoperative irradiation and chemotherapy have proven benefit in terms of prolonging disease-free survival. Stage IIIB disease without N3 involvement may be treated first with chemotherapy and radiation followed by surgery, depending on tumor response. Most surgeons consider N3 disease a sign of inoperability.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832–839.

    CAS  PubMed  Google Scholar 

  2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710–1717.

    CAS  PubMed  Google Scholar 

  3. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440–447.

    CAS  PubMed  Google Scholar 

  4. Ginsberg RJ. Preoperative assessment of the thoracic surgical patient: a surgeon’s viewpoint. In: Pearson FG, Deslauriers J, Hiebert CA, McNeally MF, Ginsberg RJ, Urschel HC (eds) Thoracic Surgery. New York: Churchill Livingstone, 1995:29–36.

    Google Scholar 

  5. O’Donovan PB. The radiologic appearance of lung cancer. Oncology 1997;11:1387–1424.

    CAS  PubMed  Google Scholar 

  6. Steele JD. The solitary pulmonary nodule. J Thorac Cardiovasc Surg 1963;46:21–39.

    CAS  PubMed  Google Scholar 

  7. Kundel HL. Predictive values and threshold detectability of lung tumors. Radiology 1981;139:25–29.

    CAS  PubMed  Google Scholar 

  8. Geddes DM. The natural history of lung cancer: a review based on rates of tumor growth. Br J Dis Chest 1979;73:1–17.

    Article  CAS  PubMed  Google Scholar 

  9. Byrd RB, Carr DT, Miller WE, et al. Radiographic abnormalities in carcinoma of the lung as related to histologic cell type. Thorax 1969;24:573–575.

    Article  CAS  PubMed  Google Scholar 

  10. Zwirewich CV, Vedal S, Miller RR, et al. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991;179:469–476.

    CAS  PubMed  Google Scholar 

  11. Primack SL, Lee KS, Logan PM, et al. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994;193:795–800.

    CAS  PubMed  Google Scholar 

  12. Gross BH, Glazer GM, Orringer MB, et al. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology 1988;166:71–74.

    CAS  PubMed  Google Scholar 

  13. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319–323.

    CAS  PubMed  Google Scholar 

  14. Maddeus M, Ginsberg RJ. Cancer: diagnosis and staging. In: Pearson FG, Deslauriers J, Hiebert CA, McNeally MF, Ginsberg RJ, Urschel HC (eds) Thoracic Surgery. New York: Churchill Livingstone, 1995:671–690.

    Google Scholar 

  15. Shields TW. Diagnosis and staging of lung cancer. In: Baue AE, Geha AS, Hammond GL, et al. (eds) Glenn’s Thoracic and Cardiovascular Surgery. Stamford, CT: Appleton & Lange, 1996;391–419.

    Google Scholar 

  16. Greco FA, Hainsworth JD. Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung. Oncology 1997;11:27–36.

    CAS  PubMed  Google Scholar 

  17. Wahl RL, Quint LE, Greenough RL. Staging of mediastinal non-small cell lung cancer with FDG, PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994;191:371–377.

    CAS  PubMed  Google Scholar 

  18. Minn H, Zasadny KR, Quint LE, et al. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology 1995;196:167–173.

    CAS  PubMed  Google Scholar 

  19. Schiepers C. Role of position emission tomography in the staging of lung cancer. Lung Cancer 1997;17(suppl 1):S29–S35.

    Article  PubMed  Google Scholar 

  20. Warren WH, Gould VE. Differential diagnosis of small cell neuroendocrine carcinoma of the lung. Chest Surg Clin N Am 1997;7:49–63.

    CAS  PubMed  Google Scholar 

  21. Urschel J. Surgical treatment of peripheral small cell lung cancer. Chest Surg Clin N Am 1997;7:95–103.

    CAS  PubMed  Google Scholar 

  22. Kohman LJ. Is there a place for surgery in central small cell lung cancer? Chest Surg Clin N Am 1997;7:105–112.

    CAS  PubMed  Google Scholar 

  23. Burt M, Heelan RT, Coit D, et al. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer: impact of magnetic resonance imaging. J Thorac Cardiovasc Surg 1994;107:584–589.

    CAS  PubMed  Google Scholar 

  24. Schwartz LH, Ginsberg MS, Burt ME, et al. MRI as an alternative to CT guided biopsy of adrenal masses in patients with lung cancer. Ann Thorac Surg 1998;65:193–197.

    Article  CAS  PubMed  Google Scholar 

  25. Gamsu G. Magnetic resonance imaging in lung cancer. Chest 1986;89:242s–244s.

    CAS  PubMed  Google Scholar 

  26. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120–129.

    Article  CAS  PubMed  Google Scholar 

  27. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: five year survival and patterns of recurrence. J Thorac Cardiovasc Surg 1994;107:1087–1094.

    CAS  PubMed  Google Scholar 

  28. Ginsburg RJ. The role of limited resection in the treatment of early stage lung cancer. Lung Cancer 1994;11(suppl 2):S35–S36.

    Google Scholar 

  29. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037–1049.

    CAS  PubMed  Google Scholar 

  30. Thomas PH, Piantadosi S, Mountain CF. Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg 1988;95:883–887.

    Google Scholar 

  31. Shields TW. Presentation, diagnosis and staging of bronchial carcinoma and of the asymptomatic solitary pulmonary nodule. In: Shields TW (ed) General Thoracic Surgery, 4th ed. Philadelphia: Williams & Wilkins, 1994:1122–1154.

    Google Scholar 

  32. Hara N, Ohta M, Tanaka K, et al. Assessment of the role of surgery for stage III bronchogenic carcinoma. J Surg Oncol 1984;25:153–158.

    CAS  PubMed  Google Scholar 

  33. Burt ME, Pomerantz AH, Bains MS, et al. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am 1987;67:987–1000.

    CAS  PubMed  Google Scholar 

  34. Raviv G, Klein E, Yellin A, et al. Surgical treatment of solitary adrenal metastases from lung carcinoma. J Surg Oncol 1990;43:123–124.

    CAS  PubMed  Google Scholar 

  35. Reyes L, Parvez Z, Nemoto T, et al. Adrenalectomy for adrenal metastasis from lung carcinoma. J Surg Oncol 1990;44:32–34.

    CAS  PubMed  Google Scholar 

  36. Luketich JD, Martini N, Ginsberg RJ, et al. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg 1995;60:1609–1611.

    Article  CAS  PubMed  Google Scholar 

  37. Wernly JA, DeMeester TR. Preoperative assessment of patients undergoing lung resection for cancer. In: Roth JA, Ruchdeschel JC, Weisenburger TH (eds) Thoracic Oncology. Philadelphia: Saunders, 1989:156–176.

    Google Scholar 

  38. Martinez FJ, Paine R. Medical evaluation of the patient with potentially resectable lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turisi AT (eds) Lung Cancer: Principles and Practice. Philadelphia: Lippincott-Raven, 1995:511–534.

    Google Scholar 

  39. Cohen MC, Eagle KA. Expert opinion regarding indications for coronary angiography before non-coronary cardiac surgery. Am Heart J 1997;134:321–329.

    Article  CAS  PubMed  Google Scholar 

  40. Goldman L. Cardiac risks and complications of non-cardiac surgery. Ann Surg 1983;198:780–791.

    Article  Google Scholar 

  41. Eagle KA. Surgical patients with heart disease: summary of the ACC/AHA guidelines. Am Fam Physician 1997;56:811–818.

    CAS  PubMed  Google Scholar 

  42. Eagle KA, Brundage BH, Chaitman BR, et al. Guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. J Am Coll Cardiol 1996;27:910–948.

    Article  CAS  Google Scholar 

  43. Olsen GN, Bolton JWR, Weiman DS, et al. Stair climbing as an exercise test to predict the postoperative complications of lung resection: two years experience. Chest 1991;99:587–590.

    CAS  PubMed  Google Scholar 

  44. Morice RC, Peters EJ, Ryan MB, et al. Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest 1992;101:356–361.

    CAS  PubMed  Google Scholar 

  45. Bechard D, Wetstein L. Assessment of exercise consumption as a preoperative criterion for lung resection. Ann Thorac Surg 1987;44:344–349.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Warren, W.H., James, T.W. (2003). Non-Small Cell Cancer of the Lung. In: Saclarides, T.J., Millikan, K.W., Godellas, C.V. (eds) Surgical Oncology. Springer, New York, NY. https://doi.org/10.1007/0-387-21701-0_19

Download citation

  • DOI: https://doi.org/10.1007/0-387-21701-0_19

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95201-7

  • Online ISBN: 978-0-387-21701-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics